Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' COLNAGHI MI' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 100 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Menard, S; Valagussa, P; Pilotti, S; Gianni, L; Biganzoli, E; Boracchi, P; Tomasic, G; Casalini, P; Marubini, E; Colnaghi, MI; Cascinelli, N; Bonadonna, G
      Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables

      JOURNAL OF CLINICAL ONCOLOGY
    2. Miotti, S; Bagnoli, M; Tomassetti, A; Colnaghi, MI; Canevari, S
      Interaction of folate receptor with signaling molecules lyn and G alpha(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1

      JOURNAL OF CELL SCIENCE
    3. Menard, S; Aiello, P; Tagliabue, E; Rumio, C; Lollini, PL; Colnaghi, MI; Balsari, A
      Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model

      CANCER RESEARCH
    4. Sfondrini, L; Rodolfo, M; Singh, M; Colombo, MP; Colnaghi, MI; Menard, S; Balsari, A
      Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice

      CANCER RESEARCH
    5. Nardini, E; Aiello, A; Giardini, R; Colnaghi, MI; Menard, S; Balsari, A
      Detection of aberrant isotype switch recombination in low-grade and high-grade gastric MALT lymphomas

      BLOOD
    6. Maier, JAM; Morelli, D; Lazzerini, D; Menard, S; Colnaghi, MI; Balsari, A
      Inhibition of fibronectin-activated migration of microvascular endothelialcells by interleukin 1 alpha, tumour necrosis factor alpha and interferon gamma

      CYTOKINE
    7. Pupa, SM; Howard, CM; Invernizzi, AM; De Vecchi, R; Giani, C; Claudio, PP; Colnaghi, MI; Giordano, A; Menard, S
      Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line

      ONCOGENE
    8. TOMASSETTI A; BOTTERO F; MAZZI M; MIOTTI S; COLNAGHI MI; CANEVARI S
      MOLECULAR REQUIREMENTS FOR ATTACHMENT OF THE GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR TO THE HUMAN ALPHA FOLATE RECEPTOR

      Journal of cellular biochemistry
    9. Menard, S; Casalini, P; Tomasic, G; Pilotti, S; Cascinelli, N; Bufalino, R; Perrone, F; Longhi, C; Rilke, F; Colnaghi, MI
      Pathobiologic identification of two distinct breast carcinoma subsets withdiverging clinical behaviors

      BREAST CANCER RESEARCH AND TREATMENT
    10. Balsari, A; Maier, JAM; Colnaghi, MI; Menard, S
      Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels,and serum angiogenic activity in patients with breast carcinoma

      LABORATORY INVESTIGATION
    11. Formantici, C; Orlandi, R; Ronchini, C; Pilotti, S; Ranzani, GN; Colnaghi, MI; Menard, S
      Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations

      JOURNAL OF PATHOLOGY
    12. Miotti, S; Negri, DRM; Valota, O; Calabrese, M; Bolhuis, RLH; Gratama, JW; Colnaghi, MI; Canevari, S
      Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival

      INTERNATIONAL JOURNAL OF CANCER
    13. Sfondrini, L; Morelli, D; Bodini, A; Colnaghi, MI; Menard, S; Balsari, A
      High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected against B16 melanoma

      INTERNATIONAL JOURNAL OF CANCER
    14. Adobati, E; Zacchetti, A; Perico, ME; Cremonesi, F; Rasi, G; Vallebona, PS; Hagenaars, M; Kuppen, PJK; Pastan, I; Panza, L; Russo, G; Colnaghi, MI; Canevari, S
      Expression profile of saccharide epitope CaMBr1 in normal and neoplastic tissue from dogs, cats, and rats: Implication for the development of human-derived cancer vaccines

      HISTOCHEMICAL JOURNAL
    15. Balsari, A; Casalini, P; Tagliabue, E; Greco, M; Pilotti, S; Agresti, R; Giovanazzi, R; Alasio, L; Rumio, C; Cascinelli, N; Colnaghi, MI; Menard, S
      Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle

      AMERICAN JOURNAL OF PATHOLOGY
    16. MORELLI D; LAZZERINI D; CAZZANIGA S; SQUICCIARINI P; BIGNAMI P; MAIER JAM; SFONDRINI L; MENARD S; COLNAGHI MI; BALSARI A
      EVALUATION OF THE BALANCE BETWEEN ANGIOGENIC AND ANTIANGIOGENIC CIRCULATING FACTORS IN PATIENTS WITH BREAST AND GASTROINTESTINAL CANCERS

      Clinical cancer research
    17. MORELLI D; LAZZERINI D; CAZZANIGA S; SQUICCIARINI P; BIGNAMI P; MAIER JAM; SFONDRINI L; MENARD S; COLNAGHI MI; BALSARI A
      EVALUATION OF THE BALANCE BETWEEN ANGIOGENIC AND ANTIANGIOGENIC CIRCULATING FACTORS IN PATIENTS WITH BREAST AND GASTROINTESTINAL CANCERS

      Clinical cancer research
    18. TAGLIABUE E; GHIRELLI C; SQUICCIARINI P; AIELLO P; COLNAGHI MI; MENARD S
      PROGNOSTIC VALUE OF ALPHA-6-BETA-4 INTEGRIN EXPRESSION IN BREAST CARCINOMAS IS AFFECTED BY LAMININ PRODUCTION FROM TUMOR-CELLS

      Clinical cancer research
    19. TAGLIABUE E; GHIRELLI C; SQUICCIARINI P; AIELLO P; COLNAGHI MI; MENARD S
      PROGNOSTIC VALUE OF ALPHA-6-BETA-4 INTEGRIN EXPRESSION IN BREAST CARCINOMAS IS AFFECTED BY LAMININ PRODUCTION FROM TUMOR-CELLS

      Clinical cancer research
    20. MIOTTI S; BAGNOLI M; TOMASSETTI A; DOLO V; COLNAGHI MI; CANEVARI S
      ALTERED EXPRESSION OF CAVEOLIN-1 ON HUMAN OVARY CARCINOMA-CELLS

      Molecular biology of the cell
    21. DOSIO F; ARPICCO S; ADOBATI E; CANEVARI S; BRUSA P; DESANTIS R; PARENTE D; PIGNANELLI P; NEGRI DRM; COLNAGHI MI; CATTEL L
      ROLE OF CROSS-LINKING AGENTS IN DETERMINING THE BIOCHEMICAL AND PHARMACOKINETIC PROPERTIES OF MGR6-CLAVIN IMMUNOTOXINS

      Bioconjugate chemistry
    22. SFONDRINI L; MORELLI D; MENARD S; MAIER JAM; SINGH M; MELANI C; TERRAZZINI N; COLOMBO MP; COLNAGHI MI; BALSARI A
      ANTITUMOR IMMUNITY INDUCED BY MURINE MELANOMA-CELLS TRANSDUCED WITH THE MYCOBACTERIUM-TUBERCULOSIS GENE ENCODING THE 38-KDA ANTIGEN

      Gene therapy
    23. Tagliabue, E; Pilotti, S; Gianni, AM; Menard, S; Colnaghi, MI
      Target molecules for immunotherapy of inflammatory breast carcinomas

      EUROPEAN JOURNAL OF CANCER
    24. GIANI C; CASALINI P; PUPA SM; DEVECCHI R; ARDINI E; COLNAGHI MI; GIORDANO A; MENARD S
      INCREASED EXPRESSION OF C-ERBB-2 IN HORMONE-DEPENDENT BREAST-CANCER CELLS INHIBITS CELL-GROWTH AND INDUCES DIFFERENTIATION

      Oncogene
    25. Mezzanzanica, D; Canevari, S; Mazzoni, A; Figini, M; Colnaghi, MI; Waks, T; Schindler, DG; Eshhar, Z
      Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells

      CANCER GENE THERAPY
    26. ARDINI E; PESOLE G; TAGLIABUE E; MAGNIFICO A; CASTRONOVO V; SOBEL ME; COLNAGHI MI; MENARD S
      THE 67-KDA LAMININ RECEPTOR ORIGINATED FROM A RIBOSOMAL-PROTEIN THAT ACQUIRED A DUAL FUNCTION DURING EVOLUTION

      Molecular biology and evolution
    27. BUTO S; TAGLIABUE E; ARDINI E; MAGNIFICO A; GHIRELLI C; VANDENBRULE F; CASTRONOVO V; COLNAGHI MI; SOBEL ME; MENARD S
      FORMATION OF THE 67-KDA LAMININ RECEPTOR BY ACYLATION OF THE PRECURSOR

      Journal of cellular biochemistry
    28. Menard, S; Tagliabue, E; Colnaghi, MI
      The 67 kDa laminin receptor as a prognostic factor in human cancer

      BREAST CANCER RESEARCH AND TREATMENT
    29. MAGNIFICO A; TAGLIABUE E; ARDINI E; CASALINI P; COLNAGHI MI; MENARD S
      HEREGULIN BETA-1 INDUCES THE DOWN-REGULATION AND THE UBIQUITIN-PROTEASOME DEGRADATION PATHWAY OF P185(HER2) ONCOPROTEIN

      FEBS letters
    30. FIGINI M; OBICI L; MEZZANZANICA D; GRIFFITHS A; COLNAGHI MI; WINTER G; CANEVARI S
      PANNING PHAGE ANTIBODY LIBRARIES ON CELLS - ISOLATION OF HUMAN FAB FRAGMENTS AGAINST OVARIAN-CARCINOMA USING GUIDED SELECTION

      Cancer research
    31. MENARD S; TOMASIC G; CASALINI P; BALSARI A; PILOTTI S; CASCINELLI N; SALVADORI B; COLNAGHI MI; RILKE F
      LYMPHOID INFILTRATION AS A PROGNOSTIC VARIABLE FOR EARLY-ONSET BREASTCARCINOMAS

      Clinical cancer research
    32. BIRINDELLI S; COLNAGHI MI; PILOTITTI S
      ADAPTATION OF THE CELLSCAN TECHNIQUE FOR THE SCM TEST IN BREAST-CANCER - COMMENT

      European journal of cancer
    33. CANEVARI S; NEGRI DRM; CALABRESE M; SILIPRANDI V; BOTTI C; SEREGNI E; COLNAGHI MI; BOLIS G
      T-CELL RETARGETING FOR LOCAL AND SYSTEMIC CONTROL OF DISEASE

      European journal of cancer
    34. ADOBATI E; PANZA L; RUSSO G; COLNAGHI MI; CANEVARI S
      IN-VITRO MIMICRY OF CAMBR1 TUMOR-ASSOCIATED ANTIGEN BY SYNTHETIC OLIGOSACCHARIDES

      Glycobiology
    35. TOMASSETTI A; MANGIAROTTI F; MAZZI M; COLNAGHI MI; MIOTTI S; NACHMANOFF K; CANEVARI S; ELWOOD PC
      TRANSCRIPTIONAL REGULATION OF THE HUMAN ALPHA-FOLATE RECEPTOR - FUNCTIONAL-ANALYSIS OF THE P1 AND P4 PROMOTERS IN OVARIAN-CARCINOMA CELL-LINES

      The FASEB journal
    36. ORLANDI R; FORMANTICI C; COLNAGHI MI; MENARD S
      BINDING-INDUCED ACTIVATION OF OVEREXPRESSED P185(HER2) IS ESSENTIAL IN TRIGGERING NEURONAL DIFFERENTIATION OF PC12 CELLS

      Journal of cellular biochemistry
    37. MIOTTI S; BAGNOLI M; OTTONE F; TOMASSETTI A; COLNAGHI MI; CANEVARI S
      SIMULTANEOUS ACTIVITY OF 2 DIFFERENT MECHANISMS OF FOLATE TRANSPORT IN OVARIAN-CARCINOMA CELL-LINES

      Journal of cellular biochemistry
    38. CANEVARI S; MEZZANZANICA D; MAZZONI A; NEGRI DRM; FIGINI M; RAMAKRISHNA V; BOLIS G; COLNAGHI MI
      APPROACHES TO IMPLEMENT BISPECIFIC ANTIBODY TREATMENT OF OVARIAN-CARCINOMA

      Cancer immunology and immunotherapy
    39. JACOBS N; MAZZONI A; MEZZANZANICA D; NEGRI DRM; VALOTA O; COLNAGHI MI; MOUTSCHEN MP; BONIVER J; CANEVARI S
      EFFICIENCY OF T-CELL TRIGGERING BY ANTI-CD3 MONOCLONAL-ANTIBODIES (MAB) WITH POTENTIAL USEFULNESS IN BISPECIFIC MAB GENERATION

      Cancer immunology and immunotherapy
    40. CASALINI P; LUISON E; MENARD S; COLNAGHI MI; PAGANELLI G; CANEVARI S
      TUMOR PRETARGETING - ROLE OF AVIDIN STREPTAVIDIN ON MONOCLONAL-ANTIBODY INTERNALIZATION/

      The Journal of nuclear medicine
    41. ARDINI E; TAGLIABUE E; MAGNIFICO A; BUTO S; CASTRONOVO V; COLNAGHI MI; MENARD S
      COREGULATION AND PHYSICAL ASSOCIATION OF THE 67-KDA MONOMERIC LAMININRECEPTOR AND THE ALPHA-6-BETA-4 INTEGRIN

      The Journal of biological chemistry
    42. CASALINI P; MENARD S; MALANDRIN SMI; RIGO CM; COLNAGHI MI; CULTRARO CM; SEGAL S
      INHIBITION OF TUMORIGENICITY IN LUNG ADENOCARCINOMA CELLS BY C-ERBB-2ANTISENSE EXPRESSION

      International journal of cancer
    43. OTTONE F; MIOTTI S; BOTTINI C; BAGNOLI M; PEREGO P; COLNAGHI MI; MENARD S
      RELATIONSHIP BETWEEN FOLATE-BINDING PROTEIN EXPRESSION AND CISPLATIN SENSITIVITY IN OVARIAN-CARCINOMA CELL-LINES

      British Journal of Cancer
    44. MIOTTI S; BAGNOLI M; TOMASSETTI A; COLNAGHI MI; CANEVARI S
      FOLATE RECEPTOR IN DETERGENT-RESISTANT COMPLEXES FROM THE OVARIAN-CARCINOMA CELL-LINE IGROVI IS ASSOCIATED TO P53-50 LYN IN THE ABSENCE OF CAVEOLIN

      Molecular biology of the cell
    45. TOSI E; VALOTA O; CANEVARI S; ADOBATI E; CASALINI P; PEREZ P; COLNAGHI MI
      ANTIIDIOTYPIC RESPONSE TO ANTIGROWTH FACTOR-RECEPTOR MONOCLONAL-ANTIBODIES

      European journal of cancer
    46. MENARD S; PUPA SM; CASALINI P; RILKE F; COLNAGHI MI
      RELATIONSHIP OF HISTOLOGIC GRADE, C-ERBB-2 EXPRESSION, AND INFLAMMATORY INFILTRATE TO PROGNOSIS IN CARCINOMA OF THE BREAST

      Journal of clinical oncology
    47. MENARD S; PUPA SM; CASALINI P; RILKE F; COLNAGHI MI
      RELATIONSHIP OF HISTOLOGIC GRADE, C-ERBB-2 EXPRESSION, AND INFLAMMATORY INFILTRATE TO PROGNOSIS IN CARCINOMA OF THE BREAST - IN REPLY

      Journal of clinical oncology
    48. PUPA SM; BUFALINO R; INVERNIZZI AM; ANDREOLA S; RILKE F; LOMBARDI L; COLNAGHI MI; MENARD S
      MACROPHAGE INFILTRATE AND PROGNOSIS IN C-ERBB-2-OVEREXPRESSING BREASTCARCINOMAS

      Journal of clinical oncology
    49. KARPATOVA M; TAGLIABUE E; CASTRONOVO V; MAGNIFICO A; ARDINI E; MORELLI D; BELOTTI D; COLNAGHI MI; MENARD S
      SHEDDING OF THE 67-KD LAMININ RECEPTOR BY HUMAN CANCER-CELLS

      Journal of cellular biochemistry
    50. BIRINDELLI S; COLNAGHI MI; PILOTTI S
      NEW SCM (STRUCTUREDNESS OF THE CYTOPLASMATIC MATRIX)-BASED APPROACH IN BREAST-CANCER DETECTION

      Tumori
    51. LI PY; DELVECCHIO S; FONTI R; CARRIERO MV; POTENA MI; BOTTI G; MIOTTI S; LASTORIA S; MENARD S; COLNAGHI MI; SALVATORE M
      LOCAL CONCENTRATION OF FOLATE BINDING-PROTEIN GP38 IN SECTIONS OF HUMAN OVARIAN-CARCINOMA BY IN-VITRO QUANTITATIVE AUTORADIOGRAPHY

      The Journal of nuclear medicine
    52. CECE R; CAZZANIGA S; MORELLI D; SFONDRINI L; BIGNOTTO M; MENARD S; COLNAGHI MI; BALSARI A
      APOPTOSIS OF HAIR FOLLICLE CELLS DURING DOXORUBICIN-INDUCED ALOPECIA IN RATS

      Laboratory investigation
    53. MAGNIFICO A; TAGLIABUE E; BUTO S; ARDINI E; CASTRONOVO V; COLNAGHI MI; MENARD S
      PEPTIDE-G, CONTAINING THE BINDING-SITE OF THE 67-KDA LAMININ RECEPTOR, INCREASES AND STABILIZES LAMININ-BINDING TO CANCER-CELLS

      The Journal of biological chemistry
    54. MORELLI D; MENARD S; COLNAGHI MI; BALSARI A
      ORAL-ADMINISTRATION OF ANTI-DOXORUBICIN MONOCLONAL-ANTIBODY PREVENTS CHEMOTHERAPY-INDUCED GASTROINTESTINAL TOXICITY IN MICE

      Cancer research
    55. RIGHETTI SC; DELLATORRE G; PILOTTI S; MENARD S; OTTONE F; COLNAGHI MI; PIEROTTI MA; LAVARINO C; CORNAROTTI M; ORIANA S; BOHM S; BRESCIANI GL; SPATTI G; ZUNINO F
      A COMPARATIVE-STUDY OF P53 GENE-MUTATIONS, PROTEIN ACCUMULATION, AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA

      Cancer research
    56. MAZZONI A; MEZZANZANICA D; JUNG GR; WOLF H; COLNAGHI MI; CANEVARI S
      CD3-CD28 COSTIMULATION AS A MEANS TO AVOIDING T-CELL PREACTIVATION INBISPECIFIC MONOCLONAL ANTIBODY-BASED TREATMENT OF OVARIAN-CARCINOMA

      Cancer research
    57. TAGLIABUE E; ARDINI E; PELLEGRINI R; CAMPIGLIO M; BUFALINO R; JESCHKE M; GRONER M; COLNAGHI MI; MENARD S
      LAMININ ACTIVATES THE P185(HER2) ONCOPROTEIN AND MEDIATES GROWTH-INHIBITION OF BREAST-CARCINOMA CELLS

      British Journal of Cancer
    58. MAIER JAM; MORELLI D; MENARD S; COLNAGHI MI; BALSARI A
      TUMOR-NECROSIS-FACTOR-INDUCED FIBROBLAST GROWTH-FACTOR-I ACTS AS A SURVIVAL FACTOR IN A TRANSFORMED ENDOTHELIAL-CELL LINE

      The American journal of pathology
    59. MENARD S; CASALINI P; PILOTTI S; CASCINELLI N; RILKE F; COLNAGHI MI
      NO ADDITIVE IMPACT ON PATIENT SURVIVAL OF THE DOUBLE ALTERATION OF P53 AND C-ERBB-2 IN BREAST CARCINOMAS

      Journal of the National Cancer Institute
    60. PELLEGRINI R; MARIOTTI A; TAGLIABUE E; BRESSAN R; BUNONE G; CORADINI D; DELLAVALLE G; FORMELLI F; CLERIS L; RADICE P; PIEROTTI MA; COLNAGHI MI; MENARD S
      MODULATION OF MARKERS ASSOCIATED WITH TUMOR AGGRESSIVENESS IN HUMAN BREAST-CANCER CELL-LINES BY N-(4-HYDROXYPLENYL)RETINAMIDE

      Cell growth & differentiation
    61. CANEVARI S; MAZZONI A; NEGRI DRM; ARIENTI F; RAMAKRISHNA V; BOLHUIS R; BOLIS G; COLNAGHI MI
      CLINICAL-RESULTS OF A NEW APPROACH OF THERAPY OF OVARIAN-CANCER - RETARGETING OF T-CELL CYTOTOXICITY BY BISPECIFIC ANTIBODIES

      European journal of cancer
    62. CASALINI P; MEZZANZANICA D; VALOTA O; ADOBATI E; TOMASSETTI A; COLNAGHI MI; CANEVARI S
      UNIDIRECTIONAL POTENTIATION OF BINDING BETWEEN 2 ANTI-FBP MABS - EVALUATION OF THE INVOLVED MECHANISMS

      Journal of cellular biochemistry
    63. MORELLI D; POZZI B; MAIER JAM; MENARD S; COLNAGHI MI; BALSARI A
      A MONOCLONAL-ANTIBODY EXTENDS THE HALF-LIFE OF AN ANTI-HIV OLIGODEOXYNUCLEOTIDE AND TARGETS IT TO CD4(+) CELLS

      Nucleic acids research
    64. BENIGNI F; CANEVARI S; GADINA M; ADOBATI E; FERRERI AJM; DICELLE EF; COLNAGHI MI; COLNAGHI MI
      PRECLINICAL EVALUATION OF THE RIBOSOME-INACTIVATING PROTEINS PAP-1, PAP-S AND RTA IN MICE

      International journal of immunopharmacology
    65. PELLEGRINI R; MARTIGNONE S; TAGLIABUE E; BELOTTI D; BUFALINO R; CASCINELLI N; MENARD S; COLNAGHI MI
      PROGNOSTIC-SIGNIFICANCE OF LAMININ PRODUCTION IN RELATION WITH ITS RECEPTOR EXPRESSION IN HUMAN BREAST CARCINOMAS

      Breast cancer research and treatment
    66. MIOTTI S; FACHERIS P; TOMASSETTI A; BOTTERO F; BOTTINI C; OTTONE F; COLNAGHI MI; BUNNI MA; PRIEST DG; CANEVARI S
      GROWTH OF OVARIAN-CARCINOMA CELL-LINES AT PHYSIOLOGICAL FOLATE CONCENTRATION - EFFECT ON FOLATE-BINDING PROTEIN EXPRESSION IN-VITRO AND IN-VIVO

      International journal of cancer
    67. MELANI C; PUPA SM; STOPPACCIARO A; MENARD S; COLNAGHI MI; PARMIANI G; COLOMBO MP
      AN IN-VIVO MODEL TO COMPARE HUMAN-LEUKOCYTE INFILTRATION IN CARCINOMAXENOGRAFTS PRODUCING DIFFERENT CHEMOKINES

      International journal of cancer
    68. TOSI E; VALOTA O; NEGRI DRM; ADOBATI E; MAZZONI A; MEAZZA R; FERRINI S; COLNAGHI MI; CANEVARI S
      ANTITUMOR EFFICACY OF AN ANTI-EPIDERMAL-GROWTH-FACTOR-RECEPTOR MONOCLONAL-ANTIBODY AND ITS F(AB')(2) FRAGMENT AGAINST HIGH-EGFR-EXPRESSING AND LOW-EGFR-EXPRESSING CARCINOMAS IN NUDE-MICE

      International journal of cancer
    69. NEGRI DRM; TOSI E; VALOTA O; FERRINI S; CAMBIAGGI A; SFORZINI S; SILVANI A; RUFFINI PA; COLNAGHI MI; CANEVARI S
      IN-VITRO AND IN-VIVO STABILITY AND ANTITUMOR EFFICACY OF AN ANTI-EGFRANTI-CD3 F(AB')(2) BISPECIFIC MONOCLONAL-ANTIBODY

      British Journal of Cancer
    70. MENARD S; CASCINELLI N; RILKE F; COLNAGHI MI
      PREDICTION OF AXILLARY LYMPH-NODE STATUS IN BREAST-CANCER PATIENTS BYUSE OF PROGNOSTIC INDICATORS

      Journal of the National Cancer Institute
    71. CANEVARI S; STOTER G; ARIENTI F; BOLIS G; COLNAGHI MI; DIRE EM; EGGERMONT AMM; GOEY SH; GRATAMA JW; LAMERS CHJ; NOOY MA; PARMIANI G; RASPAGLIESI F; RAVAGNANI F; SCARFONE G; TRIMBOS JB; WARNAAR SO; BOLHUIS RLH
      REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY

      Journal of the National Cancer Institute
    72. MANTOVANI LT; MIOTTI S; MENARD S; CANEVARI S; RASPAGLIESI F; BOTTINI C; BOTTERO F; COLNAGHI MI
      FOLATE BINDING-PROTEIN DISTRIBUTION IN NORMAL-TISSUES AND BIOLOGICAL-FLUIDS FROM OVARIAN-CARCINOMA PATIENTS AS DETECTED BY THE MONOCLONAL-ANTIBODIES MOV18 AND MOV19

      European journal of cancer
    73. CANEVARI S; COLOMBATTI M; COLNAGHI MI
      IMMUNOCONJUGATES - LESSONS FROM ANIMAL-MODELS

      Annals of oncology
    74. MIOTTI S; BAGNOLI M; OTTONE F; TOMASSETTI A; BOTTERO F; COLNAGHI MI
      FOLATE INTERNALIZATION STUDIES IN OVARY CARCINOMA-CELLS WHICH OVEREXPRESS THE HIGH-AFFINITY FOLATE RECEPTOR

      The FASEB journal
    75. BALSARI AL; MORELLI D; MENARD S; VERONESI U; COLNAGHI MI
      PROTECTION AGAINST DOXORUBICIN-INDUCED ALOPECIA IN RATS BY LIPOSOME-ENTRAPPED MONOCLONAL-ANTIBODIES

      The FASEB journal
    76. CAMPIGLIO M; TAGLIABUE E; SRINIVAS U; PELLEGRINI R; MARTIGNONE S; MENARD S; COLNAGHI MI; LOMBARDI L; MARCHISIO PC
      COLOCALIZATION OF THE P185(HER2) ONCOPROTEIN AND INTEGRIN ALPHA-6-BETA-4 IN CALU-3 LUNG-CARCINOMA CELLS

      Journal of cellular biochemistry
    77. TOMASSETTI A; BOTTERO F; CANEVAN S; MIOTTI S; MENARD S; COLNAGHI MI
      THE OVARIAN-CARCINOMA MARKER FOLATE RECEPTOR CONTRIBUTES TO THE IN-VITRO AND IN-VIVO CELL-GROWTH - EVIDENCES BY TRANSFECTION OF THE CDNA INTO NIH 3T3 CELLS/

      Journal of cellular biochemistry
    78. MORELLI D; SARDINI A; VILLA E; VILLA ML; MENARD S; COLNAGHI MI; BALSARI A
      MODULATION OF DRUG-INDUCED CYTOTOXICITY BY A BISPECIFIC MONOCLONAL-ANTIBODY THAT RECOGNIZES THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND DOXORUBICIN

      Cancer immunology and immunotherapy
    79. MORELLI D; VILLA E; TAGLIABUE E; PERLETTI L; VILLA ML; MENARD S; BALSARI A; COLNAGHI MI
      RELEVANCE OF ANTIBODY VALENCY IN EGF RECEPTOR MODULATION

      Scandinavian journal of immunology
    80. FERRINI S; SFORZINI S; CAMBIAGGI A; POGGI A; MEAZZA R; CANEVARI S; COLNAGHI MI; MORETTA L
      THE LFA-1 ICAM CELL-ADHESION PATHWAY IS INVOLVED IN TUMOR-CELL LYSIS MEDIATED BY BISPECIFIC MONOCLONAL-ANTIBODY-TARGETED T-LYMPHOCYTES/

      International journal of cancer
    81. PELLEGRINI R; MARTIGNONE S; MENARD S; COLNAGHI MI
      LAMININ RECEPTOR EXPRESSION AND FUNCTION IN SMALL-CELL LUNG-CARCINOMA

      International journal of cancer
    82. ORLANDI R; MENARD S; COLNAGHI MI; BOYER CM; FELICI F
      ANTIGENIC AND IMMUNOGENIC MIMICRY OF THE HER2 NEU ONCOPROTEIN BY PHAGE-DISPLAYED PEPTIDES/

      European Journal of Immunology
    83. CONEY LR; MEZZANZANICA D; SANBORN D; CASALINI P; COLNAGHI MI; ZURAWSKI VR
      CHIMERIC MURINE HUMAN-ANTIBODIES DIRECTED AGAINST FOLATE BINDING-RECEPTOR ARE EFFICIENT MEDIATORS OF OVARIAN-CARCINOMA CELL-KILLING

      Cancer research
    84. MENARD S; BUFALINO R; RILKE F; CASCINELLI N; VERONESI U; COLNAGHI MI
      PROGNOSIS BASED ON PRIMARY BREAST-CARCINOMA INSTEAD OF PATHOLOGICAL NODAL STATUS

      British Journal of Cancer
    85. MENARD S; SQUICCIARINI P; LUINI A; SACCHINI V; ROVINI D; TAGLIABUE E; VERONESI P; SALVADORI B; VERONESI U; COLNAGHI MI
      IMMUNODETECTION OF BONE-MARROW MICROMETASTASES IN BREAST-CARCINOMA PATIENTS AND ITS CORRELATION WITH PRIMARY TUMOR PROGNOSTIC FEATURES

      British Journal of Cancer
    86. MASTROIANNI A; INVERNIZZI L; TAGLIABUE E; FASSINA G; ALBINI A; MENARD S; COLNAGHI MI
      ALTERATION OF LAMININ PRODUCTION IN SMALL-CELL LUNG-CARCINOMA - POSSIBLE CORRELATION WITH THE ABSENCE OF THE BASEMENT-MEMBRANE

      Tumor biology
    87. PERRONE F; MENARD S; CANEVARI S; CALABRESE M; BORACCHI P; BUFALINO R; TESTORI S; BALDINI M; COLNAGHI MI
      PROGNOSTIC-SIGNIFICANCE OF THE CAMBR1 ANTIGEN ON BREAST-CARCINOMA - RELEVANCE OF THE TYPE OF RECOGNIZED GLYCOCONJUGATE

      European journal of cancer
    88. MARTIGNONE S; MENARD S; BEDINI A; PACCAGNELLA A; FASOLATO S; VEGGIAN R; COLNAGHI MI
      STUDY OF THE EXPRESSION AND FUNCTION OF THE TUMOR-ASSOCIATED ANTIGEN CAMBR1 IN SMALL-CELL LUNG CARCINOMAS

      European journal of cancer
    89. PUPA SM; MENARD S; MORELLI D; POZZI B; DEPALO G; COLNAGHI MI
      THE EXTRACELLULAR DOMAIN OF THE C-ERBB-2 ONCOPROTEIN IS RELEASED FROMTUMOR-CELLS BY PROTEOLYTIC CLEAVAGE

      Oncogene
    90. FERRINI S; CAMBIAGGI A; SFORZINI S; CANEVARI S; MEZZANZANICA D; COLNAGHI MI; MORETTA L
      USE OF ANTI-CD3 AND ANTI-CD16 BISPECIFIC MONOCLONAL-ANTIBODIES FOR THE TARGETING OF T-CELLS AND NK CELLS AGAINST TUMOR-CELLS

      Cancer detection and prevention
    91. CASALINI P; CALDERA M; CANEVARI S; MENARD S; MEZZANZANICA D; TOSI E; GADINA M; COLNAGHI MI
      A CRITICAL COMPARISON OF 3 INTERNALIZATION ASSAYS APPLIED TO THE EVALUATION OF A GIVEN MAB AS A TOXIN-CARRIER CANDIDATE

      Cancer immunology and immunotherapy
    92. SRINIVAS U; TAGLIABUE E; CAMPIGLIO M; MENARD S; COLNAGHI MI
      ANTIBODY-INDUCED ACTIVATION OF P185(HER2) IN THE HUMAN LUNG ADENOCARCINOMA CELL-LINE CALU-3 REQUIRES BIVALENCY

      Cancer immunology and immunotherapy
    93. CAPPELLARI A; BAGARELLA M; MENARD S; CALABRESE M; COLNAGHI MI
      USE OF A POOL OF MONOCLONAL-ANTIBODIES IN DIAGNOSING CELLS FROM SEROUS CAVITIES

      Tumori
    94. CANEVARI S; MIOTTI S; BOTTERO F; VALOTA O; COLNAGHI MI
      OVARIAN-CARCINOMA THERAPY WITH MONOCLONAL-ANTIBODIES

      Hybridoma
    95. LI PY; DELVECCHIO S; FONTI R; LASTORIA S; VERGARA E; CARRIERO MV; MENARD S; COLNAGHI MI; SALVATORE M
      QUANTITATION OF CA-MOV18 ANTIGEN IN SECTIONS OF OVARIAN-CARCINOMA

      The Journal of nuclear medicine
    96. FERRINI S; CAMBIAGGI A; SFORZINI S; MARCIANO S; CANEVARI S; MEZZANZANICA D; COLNAGHI MI; GROSSI CE; MORETTA L
      TARGETING OF T-LYMPHOCYTES AGAINST EGF-RECEPTOR(-CELLS BY BISPECIFIC MONOCLONAL-ANTIBODIES - REQUIREMENT OF CD3 MOLECULE CROSS-LINKING FOR T-CELL ACTIVATION() TUMOR)

      International journal of cancer
    97. BOTTINI C; MIOTTI S; FIORUCCI S; FACHERIS P; MENARD S; COLNAGHI MI
      POLARIZATION OF THE ALPHA-6-BETA-4 INTEGRIN IN OVARIAN CARCINOMAS

      International journal of cancer
    98. GESMUNDO N; CALONGHI N; SARTOR G; FARRUGGIA G; MIOTTI S; CANEVARI S; COLNAGHI MI; MASOTTI L
      EFFECT OF HYDROSTATIC-PRESSURE AND CHOLESTEROL DEPLETION ON THE EXPRESSION OF A TUMOR-ASSOCIATED ANTIGEN

      European journal of biochemistry
    99. PUPA SM; MENARD S; ANDREOLA S; COLNAGHI MI
      ANTIBODY-RESPONSE AGAINST THE C-ERBB-2 ONCOPROTEIN IN BREAST-CARCINOMA PATIENTS

      Cancer research
    100. BOTTERO F; TOMASSETTI A; CANEVARI S; MIOTTI S; MENARD S; COLNAGHI MI
      GENE TRANSFECTION AND EXPRESSION OF THE OVARIAN-CARCINOMA MARKER FOLATE BINDING-PROTEIN ON NIH 3T3 CELLS INCREASES CELL-GROWTH IN-VITRO ANDIN-VIVO/

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 02:34:37